| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |